Diversified Trust CO Axonics, Inc. Transaction History

Diversified Trust CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$56.67 - $69.36 $301,767 - $369,342	-5,325 Reduced 41.07%	7,642 $527,000
Q4 2023 Jan 08, 2024	BUY	$49.38 - $63.75 $25,924 - $33,468	525 Added 4.22%	12,967 $806,000
Q3 2023 Nov 17, 2023	BUY	$48.64 - $62.51 $79,040 - $101,578	1,625 Added 15.02%	12,442 $698,000
Q2 2023 Jul 18, 2023	BUY	$47.99 - $60.21 $139,171 - $174,609	2,900 Added 36.63%	10,817 $545,000
Q1 2023 Apr 07, 2023	BUY	$52.6 - $67.34 $80,583 - $103,164	1,532 Added 23.99%	7,917 $431,000
Q4 2022 Jan 17, 2023	BUY	$59.56 - $76.6 $60,929 - $78,361	1,023 Added 19.08%	6,385 $399,000
Q3 2022 Oct 14, 2022	SELL	$57.96 - $78.12 $73,899 - $99,603	-1,275 Reduced 19.21%	5,362 $378,000
Q2 2022 Jul 12, 2022	BUY	$39.5 - $64.42 $40,092 - $65,386	1,015 Added 18.05%	6,637 $376,000
Q1 2022 Apr 07, 2022	BUY	$43.74 - $62.76 $89,010 - $127,716	2,035 Added 56.73%	5,622 $352,000
Q4 2021 Jan 13, 2022	BUY	$50.01 - $73.35 $179,385 - $263,106	3,587 New	3,587 $201,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.